S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ONCT Oncternal Therapeutics Inc

0.5266

0.00 (0.00%)

Last Updated: 18:00:00

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Oncternal Therapeutics (NASDAQ:ONCT)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Oncternal Therapeutics Charts.

Oncternal Therapeutics (NASDAQ:ONCT)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Oncternal Therapeutics Charts.

Oncternal Therapeutics Inc News

Form 8-K - Current report
Monday 25 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Oncternal Therapeutics Announces Updated Safety and Efficacy Data for Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
Tuesday 22 October 2024 (3 months ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Tuesday 15 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 12 September 2024 (4 months ago) • Edgar (US Regulatory)

Oncternal Therapeutics Announces Termination of its Clinical Studies and Exploration of Strategic Alternatives
Thursday 12 September 2024 (4 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 8 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 9 May 2024 (8 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Friday 8 March 2024 (10 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 7 March 2024 (11 months ago) • Edgar (US Regulatory)

More Oncternal Therapeutics Inc News Articles

OMX Baltic Banks GI

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions